Nautilus Biotechnology Inc (NAUT) Q4 2024 Earnings Call Highlights: Progress in Proteome ... [Yahoo! Finance]
Nautilus Biotechnology, Inc. (NAUT)
Company Research
Source: Yahoo! Finance
Positive Points Nautilus Biotechnology Inc ( NASDAQ:NAUT ) has made significant progress in developing its proteome analysis platform, with advancements in reagent production, instrument capabilities, and software for data processing. The company has developed a large number of probes that successfully bind to epitopes spanning the human proteome, demonstrating the potential for broad-scale proteomics applications. Nautilus Biotechnology Inc ( NASDAQ:NAUT ) has shown promising results in tau proteoform analysis, which could have implications for Alzheimer's disease research and potential partnerships. The company has maintained flat operating expenses year-over-year, demonstrating effective cost management despite increased R&D and administrative expenses. Nautilus Biotechnology Inc ( NASDAQ:NAUT ) has a strong cash position with approximately $206 million in cash equivalents and investments, extending its cash runway through 2027. Negative Points The launch of Nautilus
Show less
Read more
Impact Snapshot
Event Time:
NAUT
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
NAUT alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
NAUT alerts
High impacting Nautilus Biotechnology, Inc. news events
Weekly update
A roundup of the hottest topics
NAUT
News
- Nautilus Biotechnology (NASDAQ:NAUT) was upgraded by analysts at <a style="font-weight:bold" href="https://www.wallstreetzen.com/newsletters/zen-ratings?ticker=NAUT&utm_campaign=getratings&utm_medium=online&utm_source=MarketBeat">Wall StMarketBeat
- Nautilus Biotechnology (NASDAQ:NAUT) was downgraded by analysts at <a style="font-weight:bold" href="https://www.wallstreetzen.com/newsletters/zen-ratings?ticker=NAUT&utm_campaign=getratings&utm_medium=online&utm_source=MarketBeat">Wall MarketBeat
- Nautilus Biotechnology Reports Successful Installation and Testing of its First Field Evaluation Unit at the Buck Institute for Research on AgingGlobeNewswire
- Nautilus Biotechnology (NASDAQ:NAUT) was upgraded by analysts at <a style="font-weight:bold" href="https://www.wallstreetzen.com/newsletters/zen-ratings?ticker=NAUT&utm_campaign=getratings&utm_medium=online&utm_source=MarketBeat">Wall StMarketBeat
- Nautilus Biotechnology (NASDAQ:NAUT) was upgraded by analysts at <a style="font-weight:bold" href="https://www.wallstreetzen.com/newsletters/zen-ratings?ticker=NAUT&utm_campaign=getratings&utm_medium=online&utm_source=MarketBeat">Wall StMarketBeat
NAUT
Earnings
- 4/29/25 - Beat
NAUT
Sec Filings
- 11/10/25 - Form 4
- 11/4/25 - Form 8-K
- 10/28/25 - Form 10-Q
- NAUT's page on the SEC website